tiprankstipranks
Advertisement
Advertisement

CHRS Stock Latest News

CHRS Earnings this Week: How Will it Perform?
Pre-EarningsCHRS Earnings this Week: How Will it Perform?
7d ago
CHRS
Coherus BioSciences Charts Leaner Path After Earnings Call
PremiumCompany Announcements
Coherus BioSciences Charts Leaner Path After Earnings Call
1M ago
CHRS
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
PremiumRatings
Coherus BioSciences: Buy Rating Backed by LOQTORZI’s Market Leadership and Advancing Immuno-Oncology Pipeline
2M ago
CHRS
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
PremiumRatings
Coherus: Strategic Oncology Pivot and Loqtorzi Growth Drive Buy Rating
2M ago
CHRS
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
PremiumThe Fly
Coherus Oncology reports Q4 EPS (34c), consensus (31c)
2M ago
CHRS
Options Volatility and Implied Earnings Moves Today, March 09, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves Today, March 09, 2026
2M ago
DDD
HPE
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
CHRS Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
CHRS
Coherus Biosciences Completes $47 Million Equity Offering
Premium
Company Announcements
Coherus Biosciences Completes $47 Million Equity Offering
3M ago
8K
CHRS
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
PremiumThe Fly
Coherus Oncology 28.6M share Spot Secondary priced at $1.75
3M ago
CHRS
Coherus Oncology announces common stock offering, no amount given
PremiumThe Fly
Coherus Oncology announces common stock offering, no amount given
3M ago
CHRS
Coherus Signs Clinical Supply Deal With Janssen Oncology
PremiumCompany Announcements
Coherus Signs Clinical Supply Deal With Janssen Oncology
3M ago
8K
CHRS
Coherus Biosciences Updates ATM Equity Offering Program
PremiumCompany Announcements
Coherus Biosciences Updates ATM Equity Offering Program
3M ago
8K
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
PremiumThe FlyCoherus Oncology initiated with an Outperform at Oppenheimer ahead of readouts
3M ago
CHRS
Coherus Oncology initiated with an Outperform at Oppenheimer
Premium
The Fly
Coherus Oncology initiated with an Outperform at Oppenheimer
3M ago
CHRS
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
Premium
The Fly
Coherus Oncology announces publication highlighting CCR8 antibody tagmokitug
4M ago
CHRS
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
PremiumRatings
Coherus Biosciences: Strategic Positioning and Growth Potential with Loqtorzi Leading the Charge
5M ago
CHRS
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
PremiumThe Fly
Coherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trial
5M ago
CHRS
Coherus Biosciences Divests UDENYCA Business
PremiumCompany Announcements
Coherus Biosciences Divests UDENYCA Business
6M ago
8K
CHRS
Coherus Oncology files $150M mixed securities shelf
PremiumThe Fly
Coherus Oncology files $150M mixed securities shelf
6M ago
CHRS
Coherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
PremiumCompany AnnouncementsCoherus Biosciences Earnings Call Highlights Strong Growth and Strategic Focus
6M ago
CHRS
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
Premium
Ratings
Optimistic Buy Rating for Coherus Biosciences Driven by Promising Oncology Pipeline and Strategic Focus
6M ago
CHRS
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
Premium
Ratings
Coherus Biosciences: Strategic Growth Potential and Strong Market Ambitions Justify Buy Rating
6M ago
CHRS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >